SevenBridge Financial Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.62M | Sell |
7,577
-625
| -8% | -$223K | 0.41% | 78 |
|
|
2025
Q4 | $2.87M | Sell |
8,202
-257
| -3% | -$81.5K | 0.46% | 75 |
|
|
2025
Q3 | $2.84M | Sell |
8,459
-2,689
| -24% | -$780K | 0.47% | 73 |
|
|
2025
Q2 | $3.18M | Sell |
11,148
-2,305
| -17% | -$653K | 0.56% | 59 |
|
|
2025
Q1 | $3.7M | Sell |
13,453
-4,343
| -24% | -$1.28M | 0.73% | 37 |
|
|
2024
Q4 | $5.28M | Sell |
17,796
-730
| -4% | -$217K | 1% | 23 |
|
|
2024
Q3 | $5.96M | Buy |
18,526
+1,079
| +6% | +$353K | 1.15% | 23 |
|
|
2024
Q2 | $5.74M | Buy |
17,447
+537
| +3% | +$158K | 1.27% | 18 |
|
|
2024
Q1 | $5.26M | Sell |
16,910
-291
| -2% | -$85.1K | 1.19% | 20 |
|
|
2023
Q4 | $4.95M | Buy |
17,201
+17
| +0.1% | +$4.63K | 1.17% | 22 |
|
|
2023
Q3 | $4.62M | Buy |
17,184
+713
| +4% | +$178K | 1.19% | 22 |
|
|
2023
Q2 | $3.66M | Sell |
16,471
-80
| -0.5% | -$18.6K | 0.94% | 32 |
|
|
2023
Q1 | $4M | Buy |
16,551
+98
| +0.6% | +$24.1K | 1.1% | 27 |
|
|
2022
Q4 | $4.32M | Buy |
16,453
+251
| +2% | +$67.3K | 1.26% | 23 |
|
|
2022
Q3 | $3.65M | Buy |
16,202
+398
| +3% | +$96.5K | 1.24% | 21 |
|
|
2022
Q2 | $3.85M | Sell |
15,804
-296
| -2% | -$72.5K | 1.55% | 15 |
|
|
2022
Q1 | $3.89M | Sell |
16,100
-511
| -3% | -$117K | 1.37% | 20 |
|
|
2021
Q4 | $3.74M | Sell |
16,611
-151
| -0.9% | -$31.9K | 1.13% | 25 |
|
|
2021
Q3 | $3.56M | Sell |
16,762
-663
| -4% | -$153K | 1.19% | 24 |
|
|
2021
Q2 | $4.25M | Buy |
17,425
+262
| +2% | +$64.5K | 1.38% | 16 |
|
|
2021
Q1 | $4.27M | Buy |
17,163
+64
| +0.4% | +$15.3K | 1.55% | 16 |
|
|
2020
Q4 | $3.93M | Buy |
17,099
+331
| +2% | +$76.3K | 1.54% | 17 |
|
|
2020
Q3 | $4.26M | Sell |
16,768
-13
| -0.1% | -$3.22K | 1.94% | 11 |
|
|
2020
Q2 | $3.96M | Buy |
16,781
+186
| +1% | +$42.4K | 1.97% | 11 |
|
|
2020
Q1 | $3.36M | Buy |
16,595
+212
| +1% | +$46.3K | 1.95% | 12 |
|
|
2019
Q4 | $3.95M | Sell |
16,383
-237
| -1% | -$52.2K | 1.03% | 18 |
|
|
2019
Q3 | $3.22M | Sell |
16,620
-65
| -0.4% | -$12.5K | 1.69% | 16 |
|
|
2019
Q2 | $3.08M | Buy |
16,685
+160
| +1% | +$28.6K | 1.1% | 25 |
|
|
2019
Q1 | $3.14M | Buy |
16,525
+84
| +0.5% | +$16K | 1.18% | 23 |
|
|
2018
Q4 | $3.2M | Buy |
16,441
+100
| +0.6% | +$19.5K | 1.96% | 11 |
|
|
2018
Q3 | $3.39M | Buy |
16,341
+169
| +1% | +$33.3K | 1.8% | 11 |
|
|
2018
Q2 | $2.98M | Buy |
16,172
+4
| +0% | +$708 | 1.66% | 12 |
|
|
2018
Q1 | $2.76M | Buy |
16,168
+378
| +2% | +$69.4K | 1.58% | 11 |
|
|
2017
Q4 | $2.75M | Buy |
15,790
+53
| +0.3% | +$9.38K | 1.52% | 11 |
|
|
2017
Q3 | $2.93M | Buy |
15,737
+536
| +4% | +$95K | 1.68% | 11 |
|
|
2017
Q2 | $2.62M | Buy |
15,201
+206
| +1% | +$33.5K | 1.6% | 11 |
|
|
2017
Q1 | $2.45M | Sell |
14,995
-919
| -6% | -$153K | 1.61% | 11 |
|
|
2016
Q4 | $2.62M | Hold |
15,914
| – | – | 1.9% | 7 |
|
|
2016
Q3 | $2.62M | Buy |
15,914
+422
| +3% | +$71.4K | 1.91% | 7 |
|
|
2016
Q2 | $2.36M | Buy |
+15,492
| New | +$2.41M | 1.65% | 8 |
|
Other funds holding AMGN
VCM
VPM
SevenBridge Financial Group's AMGN Position: Q1 2026 in Review
SevenBridge Financial Group reduced its Amgen (AMGN) stake by 7.6% in Q1 2026, selling an estimated $223K and leaving 7,577 shares worth $2.62M. The position accounts for 0.41% of the portfolio, ranked #78.
SevenBridge Financial Group first reported a position in AMGN in Q2 2016 and has held it in 40 quarters since. The position peaked at $5.96M in Q3 2024. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- SevenBridge Financial Group held 7,577 shares of Amgen worth $2.62M as of Q1 2026.
- SevenBridge Financial Group sold 625 Amgen shares in Q1 2026, an estimated $223K.
- Amgen made up 0.41% of SevenBridge Financial Group's portfolio in Q1 2026, its #78 holding.
- SevenBridge Financial Group first reported a position in Amgen in Q2 2016 and has held it in 40 quarters since.
- SevenBridge Financial Group's Amgen position peaked at $5.96M in Q3 2024.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on SevenBridge Financial Group's 13F filing for Q1 2026, filed 23 Apr 2026.